Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia.

Enomoto T, Tse MT, Floresco SB.

Biol Psychiatry. 2011 Mar 1;69(5):432-41. doi: 10.1016/j.biopsych.2010.09.038. Epub 2010 Dec 10.

PMID:
21146155
2.
3.

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.

Yonezawa Y, Kuroki T, Kawahara T, Tashiro N, Uchimura H.

Eur J Pharmacol. 1998 Jan 2;341(1):45-56.

PMID:
9489855
4.

Schizophrenia clues from monkeys.

Pennisi E.

Science. 1997 Aug 15;277(5328):900. No abstract available.

PMID:
9281070
5.

Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.

Lewis DA, Volk DW, Hashimoto T.

Psychopharmacology (Berl). 2004 Jun;174(1):143-50. Epub 2003 Dec 9. Review.

PMID:
15205885
7.

Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents.

Young KA, Randall PK, Wilcox RE.

Neuroreport. 1995 Dec 15;6(18):2495-9.

PMID:
8741749
8.

Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol.

Japha K, Koch M.

Psychopharmacology (Berl). 1999 Jun;144(4):347-54.

PMID:
10435407
9.

The role of dopamine and GABA in the frontal cortex of mice in modulating a motor-stimulant effect of amphetamine and cocaine.

Karler R, Calder LD, Thai DK, Bedingfield JB.

Pharmacol Biochem Behav. 1998 May;60(1):237-44.

PMID:
9610948
10.

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Egerton A, Reid L, McGregor S, Cochran SM, Morris BJ, Pratt JA.

Psychopharmacology (Berl). 2008 May;198(1):37-49. doi: 10.1007/s00213-008-1071-5. Epub 2008 Apr 23.

PMID:
18427784
13.

1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.

Pietraszek M, Michaluk J, Romańska I, Wasik A, Gołembiowska K, Antkiewicz-Michaluk L.

Neurotox Res. 2009 Nov;16(4):390-407. doi: 10.1007/s12640-009-9097-y. Epub 2009 Aug 1.

PMID:
19649683
14.

Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: drawing links to schizophrenia from preclinical research.

Tse MT, Piantadosi PT, Floresco SB.

Biol Psychiatry. 2015 Jun 1;77(11):929-39. doi: 10.1016/j.biopsych.2014.09.007. Epub 2014 Nov 18. Review.

PMID:
25442792
15.

Amphetamine sensitization in rats as an animal model of schizophrenia.

Peleg-Raibstein D, Knuesel I, Feldon J.

Behav Brain Res. 2008 Aug 22;191(2):190-201. doi: 10.1016/j.bbr.2008.03.037. Epub 2008 Apr 8.

PMID:
18486243
16.

Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats.

Howland JG, Hannesson DK, Phillips AG.

Eur J Neurosci. 2004 Nov;20(10):2639-48.

PMID:
15548207
17.
18.

Prefrontal cortical GABA modulation of spatial reference and working memory.

Auger ML, Floresco SB.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu013. doi: 10.1093/ijnp/pyu013.

19.

Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.

Elsworth JD, Groman SM, Jentsch JD, Leranth C, Redmond DE Jr, Kim JD, Diano S, Roth RH.

Int J Neuropsychopharmacol. 2014 Oct 31;18(6). pii: pyu048. doi: 10.1093/ijnp/pyu048.

20.

Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function.

Braver TS, Barch DM, Cohen JD.

Biol Psychiatry. 1999 Aug 1;46(3):312-28. Review.

PMID:
10435197

Supplemental Content

Support Center